News
Feb 22, 2023
April Johnson Stearns, Founder, and Editor-in-Chief, of WILDFIRE Magazine is leading a workshop for anyone interested in using their voice to advocate for…
Aug 03, 2022
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the APOLLO-B Phase 3 study of patisiran, an…
Jul 12, 2021
Novo Nordisk has struck a $1.2 billion deal to buy Prothena’s ATTR amyloidosis program, which was stalled by the pandemic last year.The deal will see Novo pay $100…
Apr 17, 2020
The American Society of Nuclear Cardiologyexternal link, opens in a new tab designates this live activity for a maximum of 4 CME Credits(tm). Physicians should…
Mar 27, 2020
The American Society of Nuclear Cardiology (ASNC)external link, opens in a new tab will again host the annual nuclear cardiology and cardiac CT for fellows in…
Mar 26, 2020
This discussion was recorded on March 24, 2020. American Society of Nuclear Cardiology (ASNC) leaders and global leaders in China and Singapore addressed the…
Feb 22, 2020
The Amyloidosis Foundationexternal link, opens in a new tab is proud to be a partner at this event, Amyloidosis: A Disease Now at the Forefront of Practice Latest…
AbstractThe escalating global trend of aging populations has brought attention to the rising prevalence of late-onset amyloid disorders. Among them, amyloid…
BridgeBio Pharma has secured a $300 million upfront payment through a royalty financing agreement with HealthCare Royalty and Blue Owl Capital, which will bolster…
AbstractAlzheimer’s disease (AD) is the most prevalent neurodegenerative disorder. Antiamyloid antibody treatments modestly slow disease progression in mild…